Colleen Sjogren - Feb 28, 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: Chief Commercial Officer
Signature: /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: NUVB
Transactions as of: Feb 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/4/2025, 06:36 PM
Previous filing: Apr 11, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						28K	Feb 28, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+500K		$0.00	500K	Feb 28, 2025	Class A Common Stock	500K	$1.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,000 shares acquired on November 19, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.